Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could treating sleep apnea during a COPD hospital stay keep patients out of the hospital?

NCT ID NCT03647462

Disease control Sponsor: Kaiser Permanente Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study investigates whether diagnosing obstructive sleep apnea (OSA) early and starting CPAP therapy in patients hospitalized for chronic obstructive pulmonary disease (COPD) can reduce the number of patients who are readmitted to the hospital within 30 days. Participants are Kaiser Permanente members aged 18 and older with a primary COPD diagnosis and untreated OSA. The study uses CPAP, a standard device that keeps the airway open during sleep, and tracks hospital readmissions and mortality.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Continuous Positive Airway Pressure (CPAP) therapy, a device that delivers positive air pressure to keep the airway open during sleep
What this could lead to
If successful, this could show that diagnosing and treating sleep apnea early during a COPD hospital stay lowers the chance of being readmitted within 30 days.
What could go wrong
This is a relatively small, early-stage study, and CPAP is already standard for sleep apnea; the added benefit for COPD patients is unproven, and adherence to nightly CPAP use can be challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Expected to start

Jun 2017

An estimate. Start dates often move.

Finished

Sep 2017

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Kaiser Permanente member * Males or females, any race, and age 18 and older * OSA-predominant (AHI at or above 5) sleep disordered breathing * Primary diagnosis upon admission of chronic obstructive pulmonary disease * Appropriate to perform portable sleep study while on room air (no oxygen) * Patients who are able and willing to give informed consent Exclusion Criteria: * Use of CPAP within 6 months of enrollment * Patients with CSA-predominant sleep disordered breathing * Patients who are "sleepy": ESS at or above 11 * Commercial driver's license or other occupational hazards (operating heavy machinery) * Non-English speaking (validated questionnaires are currently limited to English) * Patients with chronic respiratory failure requiring oxygen therapy or non-invasive ventilation. * Patients requiring tracheostomy * Pregnant patients

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive pulmonary disease Obstructive sleep apnea

Contacts and locations

Locations

  • Sleep Center; San Bernardino County Medical Center, Kaiser Permanente

    Fontana, California, 92335, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.